CLDN5 and post-traumatic stress disorder: As reviewed above, these were selected based on their relevance to CLDN5 (Keaney et al., 2015), aging and neurodegeneration (Jack et al., 2024), and PTSD (Wolf et al., 2024; Miller et al., 2024; Peruzzolo et al., 2022).